ABT vs SPOK · P/E 25, rev $44.33B vs P/E 17, rev $68.2M
Abbott Laboratories (ABT) versus Spok Holdings Inc (SPOK) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Spok Holdings Inc (SPOK) is a health information services company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SPOK revenue for 2026-06-30 was $68.2M. Net income was $6.1M. SPOK currently screens at market cap $215.3M and trailing P/E 17.5.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SPOK currently screens at market cap $215.3M and trailing P/E 17.5.
Not investment advice. Open the ABT and SPOK stock pages for the full models.
Not investment advice.